Effect of Simple Motor Performance on Regional Dopamine Release in the Striatum in Parkinson Disease Patients and Healthy Subjects: A Positron Emission Tomography Study

Abstract

To investigate changes in dopamine release in the striatum during motor exercise in human subjects with and without striatal dopamine denervation, eight healthy subjects and eight patients with Parkinson disease (PD) were measured during unilateral foot extension/flexion movement using positron emission tomography with [¹¹C]raclopride. Five subjects in each group were later scanned in the resting condition. Estimation of binding potential (k₃/k₄) of [¹¹C]raclopride was based on Logan plot method. Significant reductions in [¹¹C]raclopride k₃/k₄ were found in the dorsal putamen contralateral to the exercise side in the healthy group and ipsilaterally in the PD group. Spearman rank correlation analysis showed that [¹¹C]raclopride k₃/k₄ correlated inversely with the decrease in performance (velocity and motion range) in the dorsal putamen contralaterally in the healthy group and ipsilaterally in the PD group. These results suggest that simple but laborious motor exercise (motor stimulation) generates significant dopamine release in the dorsal striatum contralateral to the motor execution in humans. Lack of the crossed pattern and ipsilateral increase in dopamine release in the dorsal striatum during the unilateral limb movement may reflect the pathophysiology for hypokinetic and insufficient coordinating movement in PD.

Keywords

Motor exercise Dopamine release Dorsal striatum Parkinson's disease Positron emission tomography

Recent imaging studies indicate that mental manipulation with and without movement can change significant levels of dopamine release in the entire striatum (de la Fuente-Fernandez et al., 2001; Koepp et al., 1998). The bilateral dopamine activation has also been found in subjects after long-distance walking with fatigue (Ouchi et al., 2001). Although the dopamine release reported thus far is associated with mental activities, it remains unclear that motor tasks could increase dopamine release in the striatum or to what extent the striatum could be affected by the motor performance. It was shown that the basal ganglia serve motor control functions such as scaling or focusing of movements (Alexander and Crutcher, 1990; Alexander and DeLong, 1985; Mink and Thach, 1991). Dopamine contribution to this motor function is easily understood in view of motor impairment in parkinsonism. Thus, comparison of the normal condition with the dopamine-depletion state seen in Parkinson disease (PD) also allows us to study the dynamic aspect of pathophysiology in PD by taking advantage of D2 and −3 receptors ligand [¹¹C]raclopride ([¹¹C]RAC), the binding of which reportedly varies depending on synaptic endogenous dopamine level in vivo (Hume et al., 1992; Volkow et al., 1994).

A recent somatotopic mapping study showed that the somatotopic organization of foot representation resides in the striatum (putamen) more dorsally and more rostrally to the hand area (Maillard et al., 2000). The presence of this functional segregation pattern coincides with a known observation on PD that the nigral dopaminergic projections to the putamen are more affected than the medial striatum (Kish et al., 1988). These findings lead to the possible assumption that striatal dopamine release induced by unilateral motor task would present a region-specific alteration in [¹¹C]RAC binding in the striatum in normal condition and different responses in PD. The present study was designed to shed light on the effect of motor exercise on regional dopamine release in the striatum in vivo with and without dopaminergic denervation to the striatum by measuring striatal [¹¹C]RAC binding during unilateral foot movement in drug-naive PD patients at an early stage and age-matched healthy controls using positron emission tomography (PET).

MATERIALS AND METHODS

Patients

Eight healthy, right-handed (right-footed) subjects (male/female: 6/2; mean age ± SD: 58.0 ± 13.3 y) and eight age-matched, right-handed (right-footed) drug-naive PD patients (5/3; 61.4 ± 7.5) rated at stage 1 to 2 on the Hoehn and Yahr scale participated in the motor task study. Five subjects in each group participated in the resting condition PET study performed within one month of the motor task study. Clinical assessment of each PD patient was performed with the Unified Parkinson's Disease Rating Scale and the Mini-Mental State Examination (Table 1). Magnetic resonance imaging (MRI) study disclosed no abnormalities in the brain of each participant. Diagnostic l-dopa administration for all PD patients after first or second PET examination markedly improved parkinsonian symptoms. The present study was approved by the Ethics Committee of the Hamamatsu Medical Center, and written informed consent was obtained from all participants.

Table 1.

Clinical characteristics of patient with Parkinson disease

Patient no.	Age	Sex	DD (y)	H&Y;	MMSE	UPDRS (ADL/motor)
1	72	M	0.4	1	28	5/6
2	54	M	2	2	26	7/14
3	53	M	0.6	2	28	7/12
4	67	M	0.5	1	29	9/12
5	53	M	0.6	2	30	9/12
6	67	F	0.5	1	27	11/21
7	66	F	0.8	1	28	7/12
8	59	F	1.2	1	27	9/19

DD, disease duration, H&Y, modified Hoehn and Yahr disability score (1–5); MMSE, Mini-Mental State Examination (maximum score = 30); UPDRS, Unified Parkinson's Disease Rating Scale (ADL, activities of daily living, maximum score 52; motor, motor function, maximum score 108).

Task performance

Healthy subjects were instructed to perform right foot sequential extension/flexion movement at their own speed (close to 1 Hz) for 62 minutes in the supine position. Patients with PD were required to move the foot on the hypokinesic side at their own pace (close to 0.5 Hz). During the performance, time course changes of the following physiologic parameters were monitored: arterial blood pressure, pulse rates, and Paco₂. To quantify the reduction of the motor task, the motion speed and mobility angle of the foot at ankle were measured twice at the beginning and the end points and scored as a performance index using the following formula: |M_t=60 - M_t=1|/M_t=1, where M_t=1 denoted a product of the motion velocity and motion angle measured by a protractor at one minute, and M_t=60 at 60 minutes after task start. After each PET measurement, all participants were asked to evaluate their fatigue levels using monopolar subjective analog scales from 0 to 10 levels (from easiest to the most stressful).

Magnetic resonance imaging and positron emission tomography procedures

The procedure of MRI study was reported elsewhere (Ouchi et al., 1998). Briefly, MRI with three-dimensional-mode data acquisition was performed just before PET measurement using a static magnet (0.3 T MRP7000AD; Hitachi, Tokyo, Japan) in order to determine areas of the striatal nuclei for setting regions of interest (ROIs). In reference to measures of tilt angle and spatial coordinates obtained in the procedure for determining the intercommissural (AC-PC) line on each subject's sagittal MR images, a PET gantry was set parallel to the AC-PC line by tilting and moving the gantry for each study, which permitted the reconstruction of PET images parallel to the AC-PC line without reslicing (Ouchi et al., 1999).

Positron emission tomography was performed using a high-resolution brain PET scanner (SHR2400; Hamamatsu Photonics K.K., Hamamatsu, Japan) with a capability of the gantry tilting from −20 to +90 and moving vertically and with in-plane spatial resolution of 2.7 mm at full width at half maximum (Yamashita et al., 1990). The gantry was set parallel to the AC-PC line determined by MRI (as described in the preceding paragraph), and a 20-minute transmission scan for attenuation correction was performed with a Ge/⁶ Ga source.

In PET study, a thermoplastic face mask designed for radio-surgery was used to fix the head to the same place between the two separate PET measurements (task and rest). Serial scans (time frames: 4 × 30 s, 20 × 60 s, 8 × 300 s) and periodic arterial blood sampling were performed for 62 minutes after a slow bolus injection (taking 1 minute) of a 370-MBq dose of [¹¹C]RAC. To determine radioactive metabolites, additional arterial blood samples were drawn at 1, 5, 20, and 30 minutes after injection and analyzed using thin-layer chromatography and a storage-phospher-screen bioimaging analyzer (BAS-1500; Fuji Film, Tokyo, Japan). The free metabolite-corrected plasma activities were fitted to a sum of three exponentials by the nonlinear least squares method with the nonweighted Gauss-Newton algorithm.

Region of interest data analysis and statistics

As shown in Fig. 1, irregular ROIs (64 ∼ 800 mm²) were drawn bilaterally over the ventromedial striatum (head of the caudate), the inferolateral part (ventral putamen), and the superodorsal part (dorsal putamen) of the striatum and the cerebellum on the MR images (Mai et al., 1997; Ouchi et al., 1999) and transferred onto the corresponding [¹¹C]RAC PET images using image-processing software (Dr View; Asahi Kasei Co., Tokyo, Japan) on a SUN workstation (Hypersparc ss-20; SUN Microsystems, CA, U.S.A.) (Ouchi et al., 1999). One PET image that integrated data of 6.5-mm thickness (Yamashita et al., 1990) as a volume radioactivity contained the functional information of the striatum at least 6.5 mm deep in the z direction. Thus, in the present study we regarded the ROI value on a single PET image as a regional (volume) value of ligand uptake. Binding potential, B_max‘/k_d (or k₃/k₄), was estimated using the following equation and the nonlinear least squares fitting method: B_max‘/k_d = (target tissue V_d)/(cerebellum V_d) −1, where each V_d (distribution volume) was obtained by the Logan graphical method (Lammertsma et al., 1996; Logan et al., 1990, 1994). Although age-related reduction was reported in D2 receptors (Antonini et al., 1993), the correction for aging for PET results was not performed because no significant difference in age was observed between the PD and the healthy groups (P > 0.05, χ² test). Two-way analysis of variance (ANOVA) was first performed to assess levels of binding potentials with respect to one inter-subject factor (PD, healthy) and the intrasubject factor (hemispheric side of the striatum contralateral or ipsilateral to the exercising foot) for evaluating the interhemispheric effect due to unilateral foot movement. Because there was no significant interaction in the two-way ANOVA between the hemispheric side and types of groups, all estimates were evaluated by one-way ANOVA in each region separately with the Bonferroni test for correction of multiple comparisons. Because the post hoc multiple comparisons were performed in these analyses, statistical significance was set as P < 0.05. Repeated measures ANOVA was performed in the same way previously described to compare binding potentials between the motor task condition and the resting condition. In addition, Spearman rank correlation analysis between levels of k₃/k₄ and motor performance was performed in each subregion of the striatum. The level of significance was given as P < 0.05.

Fig. 1.

Setting of regions of interest (ROIs). Irregular ROIs, drawn bilaterally on the concerned regions on the magnetic resonance images (upper row), were placed on the corresponding positron emission tomography images (bottom row). Ce, cerebellum; Cd, caudate; V-Put, ventral putamen; D-Put, dorsal putamen.

Statistical parametric mapping analysis on [¹¹C]raclopride image

To investigate brain regions showing positive correlation between reduction in receptor binding (increase in dopamine release) and increase in burden of performance, a voxel-wise-based correlation analysis was made using statistical parametric mapping (SPM99; Wellcome Department of Cognitive Neurology, London, U.K.) (Friston et al., 1995). Based on the Logan graphical method yielding DV values, the image was generated from a measured DV image (Drevets et al., 1999). With SPM, spatial normalization of the DV image to the standard stereotaxic brain atlas (Talairach and Tournoux, 1988) was performed using transformation parameters for early integrated images of [¹¹C]RAC from 0 to 20 minutes after injection (Ito et al., 1999). After image normalization, symptom-(task-)induced hemispheric side difference in the PD group was effaced by flipping images so that the side of activation contralateral to the exercising foot was set on the left in all PD images. After smoothing images with an isotropic Gaussian kernel of 8 mm, t-statistic analysis was performed on a voxel-by-voxel basis for contrasts of the within-group condition, resulting in t-statistic maps (SPM[t]), which were subsequently transformed to the unit normal distribution (SPM[Z]). The threshold was set at Z > 3.09 without a correction for multiple comparisons, corresponding to P < 0.001 at each voxel because areas of interest were expected a priori.

RESULTS

Physiology and performance

There were no significant changes in physiologic parameters (mean arterial blood pressure, pulse rate, Paco₂) and performance at the initial and end points of foot movement between two different tracer studies in each group (P > 0.05, paired t-test) (Fig. 2). However, the magnitude of the motor stress index and the subjective analog scale was significantly greater in the PD group than in the healthy group (P < 0.05, unpaired t-test) (Fig. 2). Some PD patients ceased to move the foot intermittently but completed the task with an occasional help of verbal encouragement from the staff.

Fig. 2.

Changes in mean arterial blood pressure (A: ○ normal, ● PD [Parkinson disease]), pulse rate (A: Δ normal, ▲ PD), Paco₂ level (A: □ normal, ■ PD), and foot motion velocity (B: ○ normal, ▲ PD) and its motion angle (B: Δ normal, ▲ PD) at 1 and 60 minutes after injection in [¹¹C]raclopride study. Repeated measures ANOVA showed a significant reduction in the motion angle in PD (B: *P < 0.05). Magnitude of reduction in motor performance was significantly greater in the PD than in the normal group (C).

Changes in k₃/k₄ during foot movement. One-way ANOVA showed that the level of k₃/k₄ for [¹¹C]RAC in the dorsal putamen contralateral to the exercise side was significantly lower than that in the ventral putamen in the healthy group, whereas the k₃/k₄ level in the ipsilateral dorsal putamen was significantly lower in the PD group (Table 2). Repeated measures ANOVA showed that the percent reduction in k₃/k₄ level was significantly greater in the dorsal putamen contralaterally in the healthy group and ipsilaterally in the PD group than that in the resting condition (Fig. 3, Table 2). In the resting condition, no significant regional difference in k₃/k₄ level was observed within group (Table 2), whereas—as expected—the level in the ventral putamen in the PD group was higher than that in the healthy group.

Fig. 3.

The magnitude of percentage of reduction in [¹¹C]raclopride k₃/k₄ during motor exercise compared with the resting condition. An asterisk denotes a significant difference by repeated measures ANOVA (P < 0.05). I, ipsilateral; c, contralateral; CD, caudate; VP, ventral putamen; DP, dorsal putamen.

Table 2.

Levels of binding potentials for [¹¹C]raclopride in exercise and resting conditions

Condition	Cerebellar K₁/k₂	Ventromedial striatum		Inferolateral striatum		Superodorsal striatum
		Ipsilateral	Contralateral	Ipsilateral	Contralateral	Ipsilateral	Contralateral
		Exercise
PD	0.52 ± 0.07	1.79 ± 0.38	1.86 ± 0.38	2.33 ± 0.31	2.36 ± 0.54	1.61 ± 0.47*	1.69 ± 0.49*
N	0.51 ± 0.04	1.75 ± 0.14	1.66 ± 0.22	2.14 ± 0.17	2.07 ± 0.33	1.72 ± 0.11	1.44 ± 0.14*†
Rest
PD	0.50 ± 0.08	1.71 ± 0.40	1.87 ± 0.11	2.26 ± 0.17	2.39 ± 0.18	1.80 ± 0.31	1.82 ± 0.33
N	0.46 ± 0.07	1.93 ± 0.18	1.91 ± 0.17	2.18 ± 0.13	2.22 ± 0.10	1.99 ± 0.18	2.06 ± 0.13

Values are expressed as mean ± SD; n = 8 in each group for the exercise results, n = 5 in each group for the resting results. Ventromedial striatum refers to the head of the caudate, superodorsal striatum the dorsal putamen, and inferolateral striatum the ventral putamen.

PD, Parkinson disease; N, normal group.

P < 0.05 versus inferolateral striatum, †P < 0.05 versus resting condition.

Spearman rank correlation analysis showed that [¹¹C]RAC k₃/k₄ values correlated inversely with the performance reduction in the dorsal putamen contralateral to the motion side in healthy group (r = 0.749, P < 0.05, f(x) = −0.008x + 1.75) and ipsilateral to the motion side in PD group (r = 0.750, P < 0.05, f(x) = −0.047x + 3.60) (Fig. 4B). In the PD group, there was a tendency of inverse correlation between the caudate [¹¹C]RAC k₃/k₄ value contralateral to the motion side and the performance index (Fig. 4C).

Fig. 4.

Spearman rank correlation between [¹¹C]raclopride binding potential and performance index in the cerebellum, ventromedial caudate, superodorsal striatum, and inferolateral striatum (○: normal/ipsilateral, Δ: normal/contralateral, ●: PD [Parkinson disease]/ipsilateral, ▲: PD/contralateral). In B, [¹¹C]raclopride k₃/k₄ values correlated inversely with the magnitude of performance reduction in the dorsal putamen contralateral (dotted line) to the motion side in the normal group and ipsilaterally (straight line) in the PD group.

Changes in [¹¹C]RAC binding during the foot movement by statistical parametric mapping. Statistical parametric mapping correlation analysis using [¹¹C]RAC Vd image (reflecting binding image) showed that [¹¹C]RAC binding of the dorsal-ventral putamen contralateral to the motion side was inversely correlated with the performance reduction in healthy subjects (P < 0.001, uncorrected) (Fig. 5). In contrast, SPM with threshold of omnibus P < 0.001 failed to show significant regional changes in the PD group.

Fig. 5.

Brain regions showing significant reduction in [¹¹C]raclopride availability correlated with magnitude of performance decline during the foot movement in normal subjects. (Superodorsal putamen: [x, y, z, = −27, −15, 16, respectively], Z = 3.61; ventrolateral putamen: [x, y, z, = −29, −12, 2, respectively], Z = 3.55.) Each top row: three-dimensional glass brain views; each bottom row: detected regions superimposed on MRI scan.

DISCUSSION

The present PET study performed during simple motor task is the first to investigate the in vivo dynamics of dopamine release in human subjects with and without nigrostriatal denervation. Our result showed a significant [¹¹C]RAC binding reduction in the dorsal putamen contralateral to the exercise in healthy subjects and ipsilaterally in PD patients, suggesting an interhemispherical shift of dopaminergic activation in PD, possibly because of lack of adequate stimulation of dopamine neurons in the dorsal putamen that would have enabled repetitive motor execution. Because in vivo microdialysis studies in laboratory animals showed the effect of motor exercise on dopamine release in the striatum (Meeusen et al., 1997; Nicolaysen et al., 1988), it is likely that dopamine release in the dorsal striatum is influenced by motor exercise in the human brain.

One caveat for interpretation of this motor-effect theory was the difficulty of differentiating stress (mental activity) from motor exercise applied in the present study. Almost all the animal experiments showing dopamine release by exercise (Heyes et al., 1988; Speciale et al., 1986) concurred with the finding that more or less stress induces dopamine release (Wise, 1980). However, the motor-effect theory is supported by the lateralized dopamine activation by unilateral motor exercise in the present study and by previous findings on functional connectivity that the dorsal striatum preferentially receives inputs from motor, sensory, and premotor cortices, the ventral striatum receiving afferent inputs from limbic cortices (Brooks, 1995; Graybiel et al., 1994). This leads to the possible assumption that dopamine release in the entire striatum hints at emotional activities or mental operations, as shown in other studies (de la Fuente-Fernandez et al., 2001; Koepp et al., 1998). Furthermore, the dorsal striatum encircles the somatotopic organization of foot representation revealed by a functional MRI (Maillard et al., 2000). Because the distribution volume for [¹¹C]RAC is reportedly not dependent on regional CBF (Logan et al., 1994), which is a central biological parameter for the fMRI and [¹⁵O]H₂O PET activation studies, the present quantified changes in [¹¹C]RAC binding are probably not related to exercise-induced changes in regional CBF. Taken together, motor effect on dopamine release is likely present in the present study.

In PD, the level of [¹¹C]RAC binding was higher in the affected striatum (and even nonaffected striatum) at rest, which is consistent with results from other reports (Rinne et al., 1990; Sawle et al., 1993), presumably caused by deafferentation-induced upregulation of D2 receptors. Therefore, lack of contralateral dopamine release in the PD group in the present study may be explained not by simply mechanistic effects by the following reason: that the more severely affected putamen is incompetent to generate sufficient dopamine release. In contrast, as shown in Fig. 3, exercise-induced dopamine release was greater in the ipsilateral dorsal striatum in comparison with the baseline condition. A previous PET-CBF activation study showed that bilateral premotor cortices were activated by a unilateral hand movement after unilateral pallidotomy (Ceballos-Baumann et al., 1994), indicating compensatory functional recovery in the basal ganglia-motor cortical circuit. Histologically, afferent fibers from the dorsal part of the putamen project somatotopically to the lateral parts of the substantia nigra, which relates to the motor circuit system, and fibers from the caudate project to the rostral third of the nigra, which relates to limbic and association cortical system (Szabo, 1980; Hedreen and DeLong, 1991; Parent and Hazrati, 1994). This suggests that activation in the motor cortex or the secondary motor cortical regions would affect downwards the substantia nigra, which would in turn activate the bilateral dopaminergic systems (the more intact side could afford to release more dopamine). In the present study, a close observation of patient's behavior showed that unilateral movement of the affected limb in five of eight PD patients was accompanied irregularly by minimal movement of a clinically intact limb. The limb's movement was, however, so small in magnitude and so brief that the movement-induced activation was likely negligible. These findings suggest that the ipsilateral dorsal striatum dopamine activation in PD may not be related to the motor-induced mechanical effect, but to the compensatory effect of the dopaminergic system in maintaining the movement of an affected limb.

The present correlation of reduction in [¹¹C]RAC k₃/k₄ with performance deterioration in the dorsal striatum contralaterally in the healthy group and ipsilaterally in the PD group was intriguing. If the theory of stress on increase in striatal dopamine release during exercise was primary, [¹¹C]RAC k₃/k₄ in the more ventral and medial striatum (meso-limbo-cortical projection system) might have been a response. Actually, there was such a tendency in the PD ventromedial striatum (Fig. 4C). This quantitative change was also confirmed by correlation analysis of SPM (Fig. 5). The present correlation result is in line with the idea that dorsal striatal dopamine release is related to sensorimotor coordination and response selection (Robbins and Everitt, 1992). A failure in this correlation in the PD group in SPM might be due to the magnitude of change not being high enough to be beyond the threshold of P < 0.001. Subtraction analysis was not possible because of the low number of subjects that participated in both studies.

In conclusion, motor exercise per se could affect dopamine release in the dorsal striatum in the intact human brain contralateral to the limb being moved. In contrast, the absence of the crossed dopaminergic activation concomitant with ipsilateral increase in dopamine release may reflect the pathophysiology of PD.

Footnotes

Acknowledgements

The authors thank Fumitoshi Nakamura, Toshihiko Kanno, and Shuji Nobezawa (Hamamatsu Medical Center) for their technical support.

References

Alexander

Crutcher

(1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 13:266–271

Alexander

DeLong

(1985) Microstimulation of the primate neostriatum. Part I: physiological properties of striatal microexcitable zones. J Neurophysiol 53:1401–1416

Antonini

Leenders

Reist

Thomann

Beer

Locher

(1993) Effect of age on D2 dopamine receptors in normal human brain measured by positron emission tomography and 11C-raclopride. Arch Neurol 50:474–480

Brooks

(1995) The role of the basal ganglia in motor control: contributions from PET. J Neurol Sci 128:1–13

Ceballos-Baumann

Obeso

Vitek

Delong

Bakay

Linazasoro

Brooks

(1994) Restoration of thalamocortical activity after posteroventral pallidotomy in Parkinson's disease. Lancet 344:814

de la Fuente-Fernandez

Ruth

Sossi

Schulzer

Calne

Stoessl

(2001) Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 293:1164–1166

Drevets

Price

Kupfer

Kinahan

Lopresti

Holt

Mathis

(1999) PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum. Neuropsychopharmacology 21:694–709

Friston

Holmes

Worsley

Poline

Frith

Frackowiak

RSJ

(1995) Statistical parametric mapping in functional imaging: a general linear approach. Hum Brain Mapp 2:189–210

Graybiel

Aosaki

Flaherty

Kimura

(1994) The basal ganglia and adaptive motor control. Science 265:1826–1831

10.

Hedreen

DeLong

(1991) Organization of striatopallidal, striatonigral, and nigrostriatal projections in the macaque. J Comp Neurol 304:569–595

11.

Heyes

Garnett

Coates

(1988) Nigrostriatal dopaminergic activity is increased during exhaustive exercise stress in rats. Life Sci 42:1537–1542

12.

Hume

Myers

Bloomfield

Opacka-Juffry

Cremer

Ahier

Luthra

Brooks

Lammertsma

(1992) Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse 12:47–54

13.

Ito

Morrish

Rakshi

Uema

Ashburner

Bailey

Friston

Brooks

(1999) Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease. J Neurol Neurosurg Psychiatry 66:754–758

14.

Kish

Shannak

Hornykiewicz

(1988) Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease: pathophysiologic and clinical implications. N Engl J Med 318:876–880

15.

Koepp

Gunn

Lawrence

Cunningham

Dagher

Jones

Brooks

Bench

Grasby

(1998) Evidence for striatal dopamine release during a video game. Nature 393:266–268

16.

Lammertsma

Bench

Hume

Osman

Gunn

Brooks

Frackowiak

(1996) Comparison of methods for analysis of clinical [¹¹C]raclopride studies. J Cereb Blood Flow Metab 16:42–52

17.

Logan

Fowler

Volkow

Wolf

Dewey

Schlyer

MacGregor

Hitzemann

Bendriem

Gatley

Cristman

(1990) Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N−¹¹C-methyl]-(−)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 10:740–747

18.

Logan

Volkow

Fowler

Wang

Dewey

MacGregor

Schlyer

Gatley

Pappas

King

(1994) Effects of blood flow on [¹¹C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab 14:995–1010

19.

Mai

Assheuer

Paxinos

, eds (1997) Atlas of the human brain. San Diego, CA: Academic Press

20.

Maillard

Ishii

Bushara

Waldvogel

Schulman

Hallett

(2000) Mapping the basal ganglia: fMRI evidence for somatotopic representation of face, hand, and foot. Neurology 55:377–383

21.

Meeusen

Smolders

Sarre

de Meirleir

Keizer

Serneels

Ebinger

Michotte

(1997) Endurance training effects on neurotransmitter release in rat striatum: an in vivo microdialysis study. Acta Physiol Scand 159:335–341

22.

Mink

Thach

(1991) Basal ganglia motor control. Part I: nonexclusive relation of pallidal discharge to five movement modes. J Neurophysiol 65:273–300

23.

Nicolaysen

Ikeda

Justice

JBJ

Neill

(1988) Dopamine release at behaviorally relevant parameters of nigrostriatal stimulation: effects of current and frequency. Brain Res 460:50–59

24.

Ouchi

Nobezawa

Okada

Yoshikawa

Futatsubashi

Kaneko

(1998) Altered glucose metabolism in the hippocampal head in memory impairment. Neurology 51:136–142

25.

Ouchi

Yoshikawa

Okada

Futatsubashi

Sekine

Iyo

Sakamoto

(1999) Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for beta-CFT binding with positron emission tomography. Ann Neurol 45:601–610

26.

Ouchi

Kanno

Okada

Yoshikawa

Futatsubashi

Nobezawa

Torizuka

(2001) Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease. Brain 124:784–792

27.

Parent

Hazrati

(1994) Multiple striatal representation in primate substantia nigra. J Comp Neurol 344:305–320

28.

Rinne

Laihinen

Nagren

Bergman

Solin

Haaparanta

Ruotsalainen

Rinne

(1990) PET demonstrates different behavior of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease. J Neurosci Res 27:494–499

29.

Robbins

Everitt

(1992) Functions of dopamine in the dorsal and ventral striatum. Semin Neurosci 4:119–127

30.

Sawle

Playford

Brooks

Quinn

Frackowiak

(1993) Asymmetrical pre-synaptic and post-synaptic changes in the striatal dopamine projection in dopa naive parkinsonism. Diagnostic implications of the D2 receptor status. Brain 116:853–867

31.

Speciale

Miller

McMillen

German

(1986) Activation of specific central dopamine pathways: locomotion and footshock. Brain Res Bull 16:33–38

32.

Szabo

(1980) Organization of the ascending striatal afferents in monkeys. J Comp Neurol 186:307–321

33.

Talairach

Tournoux

(1988) Co-planer stereotaxic atlas of the human brain: 3-dimensional proportional system: an approach to cerebral imaging. Stuttgart, Germany: Georg Thieme

34.

Volkow

Wang

Fowler

Logan

Schlyer

Hitzemann

Lieberman

Angrist

Pappas

MacGregor

(1994) Imaging endogenous dopamine competition with [¹¹C]raclopride in the human brain. Synapse 16:255–262

35.

Wise

(1980) The dopamine synapse and the notion of “pleasure center” in the brain. Trends Neurosci 3:91–94

36.

Yamashita

Uchida

Okada

Kurono

Takemori

Watanabe

Shimizu

Yoshikawa

Ohmura

Satoh

Tanaka

(1990) Development of a high resolution PET. IEEE Trans Nucl Sci 37:594–599

Effect of Simple Motor Performance on Regional Dopamine Release in the Striatum in Parkinson Disease Patients and Healthy Subjects: A Positron Emission Tomography Study

Abstract

Keywords

MATERIALS AND METHODS

Patients

Task performance

Magnetic resonance imaging and positron emission tomography procedures

Region of interest data analysis and statistics

Statistical parametric mapping analysis on [11C]raclopride image

RESULTS

Physiology and performance

DISCUSSION

Footnotes

Acknowledgements

References

Statistical parametric mapping analysis on [¹¹C]raclopride image